A Common Drug Causing a Common Side Effect at an Uncommon Time: Metformin-Induced Chronic Diarrhea and Weight Loss After Years of Treatment.

Karthik Subramaniam, Manoj P Joseph, Lakshmi A Babu
{"title":"A Common Drug Causing a Common Side Effect at an Uncommon Time: Metformin-Induced Chronic Diarrhea and Weight Loss After Years of Treatment.","authors":"Karthik Subramaniam, Manoj P Joseph, Lakshmi A Babu","doi":"10.2337/cd20-0101","DOIUrl":null,"url":null,"abstract":"Type 2 diabetes is a common condition, with a worldwide prevalence of 9.3% as of 2019 (1). Metformin is the most common drug used and is the first-line agent in type 2 diabetes management. It is also considered one of the safest pharmacological agents for the treatment of the disease. However, gastrointestinal side effects are common, occurring in up to 75% of those who takemetformin (2). These side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and/or flatulence, with severity ranging from mild to severe. These complications are more common with immediate-release preparations of metformin than with its extended-release formulation. Discontinuation and nonadherence rates have been as high as 46% with metformin because of these issues (3).","PeriodicalId":519493,"journal":{"name":"Clinical Diabetes : A Publication of the American Diabetes Association","volume":"39 2","pages":"237-240"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061542/pdf/diaclincd200101.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes : A Publication of the American Diabetes Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd20-0101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Type 2 diabetes is a common condition, with a worldwide prevalence of 9.3% as of 2019 (1). Metformin is the most common drug used and is the first-line agent in type 2 diabetes management. It is also considered one of the safest pharmacological agents for the treatment of the disease. However, gastrointestinal side effects are common, occurring in up to 75% of those who takemetformin (2). These side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and/or flatulence, with severity ranging from mild to severe. These complications are more common with immediate-release preparations of metformin than with its extended-release formulation. Discontinuation and nonadherence rates have been as high as 46% with metformin because of these issues (3).
一种常见的药物在不常见的时间引起常见的副作用:二甲双胍引起的慢性腹泻和多年治疗后体重下降。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书